Lipoprotein abnormalities in diabetes mellitus.
In most diabetic patients, insulin or sulfonylurea treatment also resolves the characteristic triglyceride elevation. However, patients with central obesity or familial hypertriglyceridemia may require a lipid-lowering drug.
University of Washington, Seattle.
J D
JD
Brunzell
D000273:Adipose Tissue / Q000737:chemistry; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D048909:Diabetes Complications; D006442:Glycated Hemoglobin / Q000032:analysis / Q000187:drug effects; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008071:Lipoprotein Lipase / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D009132:Muscles / Q000737:chemistry; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D000960:Hypolipidemic Agents; D007328:Insulin; D008071:Lipoprotein Lipase; D013453:Sulfonylurea Compounds; D014280:Triglycerides